Analyst Price Target is $17.50
▲ +129.96% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Orchestra BioMed in the last 3 months. The average price target is $17.50, with a high forecast of $20.00 and a low forecast of $15.00. The average price target represents a 129.96% upside from the last price of $7.61.
Current Consensus is
Buy
The current consensus among 3 contributing investment analysts is to buy stock in Orchestra BioMed. This Buy consensus rating has held steady for over two years.